Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 20 Dec 2024 – 20 Aug 2026, limited by Quantum Ethical Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Quantum Ethical Fund | Nifty 500 |
|---|---|---|
| 20 Dec 2024 | ₹100.00 | ₹100.00 |
| 09 Feb 2025 | ₹97.20 | ₹96.98 |
| 31 Mar 2025 | ₹92.20 | ₹95.61 |
| 21 May 2025 | ₹97.70 | ₹101.84 |
| 11 Jul 2025 | ₹99.70 | ₹104.32 |
| 30 Aug 2025 | ₹98.20 | ₹100.64 |
| 20 Oct 2025 | ₹99.30 | ₹106.26 |
| 10 Dec 2025 | ₹96.50 | ₹104.88 |
| 29 Jan 2026 | ₹93.10 | ₹103.65 |
| 21 Mar 2026 | ₹87.50 | ₹95.56 |
| 11 May 2026 | ₹95.40 | ₹102.13 |
| 30 Jun 2026 | ₹94.30 | ₹103.03 |
| 20 Aug 2026 | ₹101.60 | ₹105.35 |
| Metric | Quantum · Regular NAV ₹10.16 Very High risk ★★☆☆☆ 1Y | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +1.40% | +5.83% | |
| — | +15.63% | |
| — | +13.23% | |
| — | +13.85% | |
| +0.96% | +12.26% | |
| +6.38% | — | |
| — | +15.60% | |
| — | +14.52% | |
| — | +13.74% | |
| Risk | ||
| 13.75% | 15.62% | |
| -0.37 | 0.43 | |
| -0.51 | 0.59 | |
| -17.01% | -23.65% | |
| Nifty 500 | — | |
| — | +3.42% | |
| — | 0.95 | |
| — | 105.9% | |
| — | 93.6% | |
| 2.30% | 2.39% | |
| ₹104.72Cr | ₹1,161Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹500 | — | |
| 13% | 45% | |
| Chirag Mehta · 1.7y | — | |
| 20 Dec 2024 | — | |
| 45 | — | |
| 33.9% | — | |
| 6.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.